Purchase Order W91YU014P0248
Award Date 4/23/14
Potential Completion Date 9/30/16
Potential Value $375K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bridgeville, PA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price contract awarded by the U.S. Army Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics, for $99,600.00. The contract is for newborn screening services, which involve testing infants for conditions such as galactosemia, hypothyroidism, sickle cell disease, and cystic fibrosis. Perkinelmer Genetics, a subsidiary of Revvity Inc., is the prime contractor and will perform the screening tests at its own laboratories. This contract does not...
- This contract was awarded by the U.S. Department of the Army Medical Command to Perkinelmer Genetics, Inc., a for-profit medical services provider, to conduct newborn screening testing. The contract has a firm fixed price of $148,000.00 and a completion date of September 30, 2020. Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc., specializes in newborn and genetic screening services to support military hospitals and treatment facilities in the U.S. and overseas. This...
- This is a firm fixed price contract awarded by the U.S. Department of Defense's Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics, for $91,840.00. The contract is for newborn screening services, which involves testing infants for conditions such as galactosemia, hypothyroidism, sickle cell disease, and cystic fibrosis. Perkinelmer Genetics is the prime contractor and does not appear to have any major subcontractors. This contract is not associated with a...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Revvity Omics Inc., doing business as Perkinelmer Genetics, to provide newborn genetic screening services in accordance with the contract's Performance Work Statement. The $197,264 contract has an ultimate completion date of August 9, 2028. Perkinelmer Genetics is a subsidiary of the parent company Revvity Inc., which provides medical imaging products and services to federal agencies. This contract does not...
- This is a firm fixed price contract awarded by the Medical Command (MEDCOM) of the U.S. Army to Revvity Omics Inc., doing business as Perkinelmer Genetics, for newborn screening services at the William Beaumont Army Medical Center in Fort Bliss, Texas. The contract has a ceiling value of $99,600.00 and a performance period through October 31, 2017. Perkinelmer Genetics is a subsidiary of the parent company Revvity Inc., which specializes in medical imaging and genetic testing products and...
- The Department of the Army Medical Command awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening tests. The contract has a potential value of $143,440.00 and a performance period ending on September 30, 2018. Perkinelmer Genetics, a subsidiary of Revvity Inc., specializes in newborn and genetic screening services, and has provided similar testing support to military hospitals and treatment...
- This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Revvity Omics Inc., doing business as Perkinelmer Genetics, for newborn screening services. The contract has a ceiling value of $371,000.00 and a period of performance from October 1, 2021 through September 30, 2024. Perkinelmer Genetics will provide screening of newborns for inherited metabolic disorders and other conditions, as recommended by the American College of Medical Genetics, for military...
- This is a firm fixed-price blanket purchase agreement (BPA) call award issued by the U.S. Army Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics. The $150,000.00 contract is for newborn screening tests and does not have a set-aside designation. Perkinelmer Genetics is a for-profit subsidiary of Revvity Inc. that specializes in medical imaging and genetic testing services, particularly newborn screening programs that test infants for conditions like...
- This is a delivery order contract awarded by the Medical Command, a defense agency, to Revvity Omics Inc., doing business as Perkinelmer Genetics, for a total ceiling value of $82,500.00. The contract is for newborn screening testing services to be provided in Germany. The award is not associated with a larger contract vehicle, and there is no set-aside designation indicated. Perkinelmer Genetics is a subsidiary of the parent company Revvity Inc., which specializes in medical imaging and genetic...
- This contract was awarded by the Department of the Army Medical Command to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening testing services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price, and has a potential value of $150,000.00. The services under this contract include testing newborns for conditions such as glucose-6-phosphate dehydrogenase deficiency, galactosemia, congenital hypothyroidism, and hemoglobinopathies. These...